STCube

STCube ROCE

The Return on Capital Employed (ROCE) of STCube (052020.KQ) as of Oct 24, 2026 is -32.55 %. In the previous year, Return on Capital Employed (ROCE) was -23.99 % — a change of 35.67% (lower).

ROCE

-32.55 %

YoY

35.67%

Last updated:

In 2025, STCube's return on capital employed (ROCE) was -32.55 %, a 35.67% increase from the -23.99 % ROCE in the previous year.

The STCube ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-27.85 KRW
Jan 1, 2019
-33.60 KRW
Jan 1, 2020
-34.89 KRW
Jan 1, 2021
-117.23 KRW
Jan 1, 2022
-37.01 KRW
Jan 1, 2023
-73.75 KRW
Jan 1, 2024
-23.99 KRW
Jan 1, 2025
-32.55 KRW
The STCube ROCE history
YEARROCEYoY
-32.55 %+35.67%
-23.99 %-67.47%
-73.75 %+99.27%
-37.01 %-68.43%
-117.23 %+235.98%
-34.89 %+3.85%
-33.60 %+20.65%
-27.85 %-62.86%
-74.98 %+837.20%
-8.00 %-62.01%
-21.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

STCube Stock analysis

What does STCube do? STCube Inc. generates revenue through its two business segments. The IT segment distributes CCTV lenses and related components, targeting businesses requiring security solutions. The BT segment develops and licenses immunomodulatory anticancer drug therapeutic candidates, selling to pharmaceutical companies and research institutions. Both segments operate under the company's brand, leveraging its IT and biotechnology expertise. The IT segment focuses on closed-circuit television lens distribution, serving commercial and industrial clients seeking reliable security infrastructure. The BT segment's drug development and licensing activities cater to the pharmaceutical industry, providing innovative therapeutic candidates for cancer treatment. These offerings align with STCube's dual expertise in technology and biotechnology. STCube's revenue streams are derived from product distribution in the IT sector and licensing agreements in the biotechnology sector. The company's clients include businesses needing CCTV components and pharmaceutical firms interested in anticancer drug development. This dual approach allows STCube to serve distinct market segments with specialized solutions. STCube is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling STCube's Return on Capital Employed (ROCE)

STCube's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing STCube's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

STCube's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in STCube’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about STCube stock

Return on Capital Employed (ROCE) of STCube is -32.55 % in 2025.

Return on Capital Employed (ROCE) of STCube changed from -23.99 % to -32.55 %, representing a 35.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) STCube since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s STCube with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — STCube

All Key Metrics — STCube